| # | Drug | Count |
|---|---|---|
| 0 | TEMOZOLOMIDE | 136 |
| 1 | CAPECITABINE | 17 |
| 2 | BEVACIZUMAB | 9 |
| 3 | LOMUSTINE | 9 |
| 4 | OLAPARIB | 3 |
| 5 | AFATINIB | 2 |
| 6 | CARBOPLATIN | 2 |
| 7 | ETOPOSIDE | 2 |
| 8 | ISOTRETINOIN | 2 |
| 9 | KETOCONAZOLE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEMOZOLOMIDE | 136 | 0.0064 |
| 1 | LOMUSTINE | 9 | 0.0035 |
| 2 | PASIREOTIDE | 2 | 0.0009 |
| 3 | IVOSIDENIB | 1 | 0.0005 |
| 4 | TRABECTEDIN | 1 | 0.0004 |
| 5 | AFATINIB | 2 | 0.0003 |
| 6 | CABERGOLINE | 1 | 0.0002 |
| 7 | CAPECITABINE | 17 | 0.0002 |
| 8 | TOPOTECAN | 1 | 0.0002 |
| 9 | OLAPARIB | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkylating Drug [EPC] | 136 | 0.0006 |
| 1 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 2 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 3 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 17 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 2 | 0.0000 |